[144] Littelfuse Inc SEC Filing

Rhea-AI Filing Summary

Littelfuse Inc (LFUS) filed a Form 144 notice of a proposed sale under Rule 144 for 2,343 common shares to be sold on NASDAQ through Merrill (8890 Lyra Dr, Columbus, OH), with an aggregate market value of $576,039 and an approximate sale date of 08/11/2025. The filing shows 24,781,558 shares outstanding. The 2,343 shares were acquired via stock option exercises: 911 shares on 04/26/2019 and 1,432 shares on 04/23/2020, and payment is listed as cash. The filer reported Nothing to Report for securities sold in the past three months and attests they have no undisclosed material adverse information about the issuer.

Insights

Financial Analyst

TL;DR: Small insider sale notice; size appears immaterial to company equity on its face.

The Form 144 documents a proposed sale of 2,343 common shares valued at $576,039. Given the reported 24,781,558 shares outstanding, the filing indicates a modest block relative to total equity. The shares were acquired through prior stock option exercises in 2019 and 2020 and are to be sold through Merrill with cash planned as consideration. From a financial-materiality standpoint, this notice alone is routine disclosure of an insider intent to sell and does not by itself indicate company-level operational or financial change.

Corporate Governance Expert

TL;DR: Standard Rule 144 disclosure; procedural compliance with attestation language is present.

The filing contains the standard attestation that the seller is not aware of undisclosed material adverse information and provides acquisition dates and nature (stock option exercises). Broker and exchange details are specified, and the filer reports no sales in the prior three months. This form fulfills regulatory notice requirements for an insider sale; it raises governance transparency but presents no immediate governance red flags based solely on the disclosed information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill 8890 Lyra Dr 5th Flr Columbus OH 43240	2343	576039.00	24781558	08/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/26/2019	Stock option exercise	Littelfuse, Inc			911	08/11/2025	cash
Common	04/23/2020	Stock option exercise	Littelfuse Inc			1432	08/11/2025	cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Littelfuse (LFUS) propose to sell according to the Form 144?

The notice proposes sale of 2,343 common shares of Littelfuse with an aggregate market value of $576,039.

When and where is the proposed sale scheduled in the Form 144?

The approximate date of sale is listed as 08/11/2025, and the securities are to be sold on NASDAQ through Merrill.

How and when were the shares acquired that are being offered for sale?

The filing shows the shares were acquired by stock option exercises: 911 shares on 04/26/2019 and 1,432 shares on 04/23/2020.

Were there any securities sold in the past three months by the filer?

The Form 144 states Nothing to Report for securities sold during the past three months.

What attestation does the filer make in the Form 144?

The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.